Levofloxacin, Bismuth, Amoxicillin and Esomeprazole As Second-Line Helicobacter pylori Therapy After Failure of Non-Bismuth Quadruple Therapy

被引：0
|
作者：
Song, Zhiqiang
Zhou, Liya
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)32965-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1340
引用
收藏
页码：S879 / S879
页数：1
相关论文
共 50 条
  • [41] META-ANALYSIS OF LEVOFLOXACIN-CONTAINING TRIPLE THERAPY VERSUS BISMUTH-CONTAINING QUADRUPLE THERAPY AS SECOND-LINE TREATMENT IN THE ERADICATION OF HELICOBACTER PYLORI
    Marin, A. C.
    McNicholl, A. G.
    Gisbert, J. P.
    HELICOBACTER, 2011, 16 : 132 - 132
  • [42] Second line bismuth-containing quadruple therapy for Helicobacter pylori eradication in Korea
    Cho, M.
    Hwang, H.
    Kim, Y.
    Lim, C.
    Oh, J.
    HELICOBACTER, 2019, 24
  • [43] Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea
    Cheon, Jae Hee
    Kim, Nayoung
    Lee, Dong Ho
    Kim, Jung Mogg
    Kim, Joo Sung
    Jung, Hyun Chae
    Song, In Sung
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (05) : 515 - 519
  • [44] TREND IN HELICOBACTER PYLORI ERADICATION RATES BY SECOND-LINE BISMUTH-BASED QUADRUPLE THERAPY AND RELATED FACTORS IN ERADICATION THERAPY
    Kim, S.
    Park, M.
    Park, S.
    Moon, W.
    Park, S.
    Jo, J.
    Kim, S.
    HELICOBACTER, 2015, 20 : 94 - 94
  • [45] Furazolidone,amoxicillin,bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori
    Hong Cheng
    World Journal of Gastroenterology, 2009, 15 (07) : 860 - 864
  • [46] Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori
    Cheng, Hong
    Hu, Fu-Lian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (07) : 860 - 864
  • [47] Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
    Jheng, Guang-Hong
    Wu, I-Chen
    Shih, Hsiang-Yao
    Wu, Meng-Chieh
    Kuo, Fu-Chen
    Hu, Huang-Ming
    Liu, Chung-Jung
    Hsu, Wen-Hung
    Hu, Chi-Tan
    Bair, Ming-Jong
    Kuo, Chao-Hung
    Wu, Deng-Chyang
    Hsu, Ping-, I
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [48] Letter: bismuth, levofloxacin, amoxicillin, PPI quadruple therapy is not an effective first or second line regimen in the presence of levofloxacin resistance
    Graham, D. Y.
    Lu, H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (11) : 1220 - 1221
  • [49] Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori
    Marin, Alicia C.
    McNicholl, Adrian G.
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2011, 140 (05) : S880 - S880
  • [50] Levofloxacin/Amoxicillin-Based Regimens Versus Quadruple Therapy for Helicobacter pylori Eradication in Second-Line: A Meta-Analysis
    Di Caro, Simona
    Fini, Lucia
    Daoud, Yayha
    Laghi, Luigi
    Gasbarrini, Antonio
    McCartney, Sara
    Bloom, Stuart L.
    GASTROENTEROLOGY, 2011, 140 (05) : S879 - S879
12345